• Save the Date: 2nd Annual Georgetown University Center for Healthy Aging Symposium, July 12, 2023

    Please save the date on Wednesday, July 12, 2023, from 9 am to 5 pm, for the 2nd Annual Georgetown Center for Healthy Aging Symposium. This event is an opportunity to gather with colleagues to share

    Categories: Announcements, Story

  • Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors

    Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today in the Journal of Clinical Oncology, adds important evidence to that potential link.

    Category: Story

  • Healthy Aging Symposium Promotes Collaboration Across Disciplines

    With more than 300 registrants in person and via Zoom, the first annual Healthy Aging Symposium at Georgetown brought together students, faculty, researchers and those who work in the field of aging for panel discussions, poster presentations and networking.

    Category: Story

  • Healthy Aging Symposium

    Plan to attend the first annual symposium focused on aging. This event is free and open to all members of the Georgetown community and our community collaborators and partners.

    Presenters will be addressing critical issues in aging research, policy and care from cells to society and include transdisciplinary researchers from several Georgetown Schools, cross-campus programs, community groups, MedStar Health and the NIH.

    Our goal is to have attendees get to know others interested in aging, describe resources, and stimulate people coming together to form new teams to address challenges of an aging society.

    Categories: Events, Story

  • Research Reveals How Aging Cells Can Be an Underlying Cause of Kidney Damage

    A study in mice by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that stress and tissue damage initiated by angiotensin II, a molecule that is known to increase blood pressure and stiffening in the linings of blood vessels, leads to cellular senescence, a process by which a cell ages and permanently stops dividing but does not die. Importantly, when the researchers eliminated senescent cells from the mice, tissues returned to a normal state in spite of a continued infusion of angiotensin II.

    Category: Story Tag:

  • Reducing your risk of cognitive disease: A $12M research study, 60 years in the making

    A McCourt researcher has dedicated her career to aging research and a decades-old study, revealing a non-medical intervention that proves resilient against dementia.

    Category: Story

  • Trial Stopped Early: Giving Immunotherapy Before Targeted Rx Improves Survival in Advanced Melanoma

    More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment with targeted therapies. The finding comes from a clinical trial that was stopped early because definitive results became apparent sooner than expected. It provides strong evidence for how best to treat patients with melanoma that has a specific mutation: Immunotherapy is the better initial approach even for people whose tumors have a mutation that could be treated by targeted therapies.

    Category: Story

  • Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease

    In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and nonmotor (cognition and quality of life) decline in the long term.

    Category: Story

  • Adult Gerontology Acute Care Nurse Practitioner Program Extends Values-Based Education Across United States

    When Dr. Kelly Thompson-Brazill first joined Georgetown’s faculty five years ago, she attended a simulation exercise and debriefing session for students in the Adult Gerontology Acute Care Nurse Practitioner Program at the School of Nursing & Health Studies.

    Category: Story

  • Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an Optimal Time for Motor Recovery After Stroke in Humans

    A phase II randomized clinical trial found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should begin 60 to 90 days after the event. The study, conducted by Georgetown University and MedStar National Rehabilitation Network (NRH) researchers, was published September 20, 2021, in PNAS (Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an Optimal Time for Motor Recovery After Stroke in Humans).

    Category: Story